COMMUNIQUÉS West-GlobeNewswire

Propanc Biopharma Announces Compelling New Preclinical Pancreatic Cancer Data for PRP Showing >90% Tumor Growth Inhibition and >2.5-Fold Survival Benefit
27/08/2026
Differentiated Profile versus RAS-Targeted Approaches Including Revolution Medicines’ Daraxonrasib MELBOURNE, Australia, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “ [...]
Orchestra BioMed to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
27/08/2026
NEW HOPE, Pa., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk- [...]
ICU Medical to Participate in Upcoming Investor Conferences
27/08/2026
SAN CLEMENTE, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced its participation in the [...]
Ambros Therapeutics Announces Appointments of John C. Jacobs and Scott Robertson to Board of Directors
27/08/2026
SAN DIEGO, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Ambros Therapeutics, Inc., today announced the appointments of John C. Jacobs and Scott Robertson to its Board of Directors. Mr. Jacobs is a seasoned industry leader with [...]
The International Myeloma Foundation Wants You to #KnowMyeloma for Blood Cancer Awareness Month 2026
27/08/2026
STUDIO CITY, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Designated in 2010 by U.S. Congress, September Blood Cancer Awareness Month aims to create awareness, increase fundraising, and support patients affected by all [...]
argenx Completes Acquisition of Forte Biosciences, Inc.
27/08/2026
Acquisition adds first-in-class anti-CD122 Antibody, FB102, to argenx’s immunology pipeline August 27, 2026 – 8:50 AM ET Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology innovation [...]
Codexis to Participate in Cantor Global Healthcare Conference 2026
27/08/2026
REDWOOD CITY, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex therapeutics, today announced the [...]
Power to Decide Announces Lori Adelman as Chief Executive Officer
27/08/2026
Washington, D.C., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Today, Power to Decide announces that Lori Adelman will join the organization as Chief Executive Officer, effective September 14, 2026. Adelman brings nearly two [...]
CalciMedica Announces One-for-Five Reverse Stock Split
27/08/2026
CalciMedica’s Common Stock to Begin Trading on a Post-Split Adjusted Basis on August 31, 2026 LA JOLLA, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- CalciMedica Inc. (“CalciMedica” or the “Company”) (Nasdaq: CALC), a [...]
National Can-RISE Study to Help Close Critical Gaps in Menopause Research
27/08/2026
The first national investigator-led study focused on Canadian women’s experiences of menopause and the menopausal transition is now inviting participants, in partnership with GreenShield and supported by a charitable [...]
L’étude Can-RISE nationale aide à combler les lacunes en recherche sur la ménopause
27/08/2026
En collaboration avec GreenShield et à travers une subvention philanthropique d’Organon, les personnes admissibles sont désormais invitées à prendre part à la première étude nationale menée par des chercheurs reposant [...]
Moleculin CEO, Walter Klemp, Participates in the Virtual Investor “Why Now” On-Demand Conference
27/08/2026
- Video webcast now available here HOUSTON, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced that it participated in the Virtual Investor “Why [...]
Ernexa Therapeutics Participates in the Virtual Investor "Why Now" On-Demand Conference
27/08/2026
Video webcast now available here CAMBRIDGE, Mass., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatment of advanced cancer and [...]
GRI Bio Featured in "Why Now" On-Demand Video Webcast
27/08/2026
Video webcast now available here LA JOLLA, CA, Aug. 27, 2026 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company developing innovative therapies for inflammatory, [...]
Akari Therapeutics Participates in the Virtual Investor "Why Now" On-Demand Conference
27/08/2026
Video webcast now available here TAMPA, Fla. and LONDON, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel [...]
Outlook Therapeutics CEO, Bob Jahr, Participates in the Virtual Investor “Why Now” On-Demand Conference
27/08/2026
Video webcast now available here ISELIN, N.J., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on the development and commercialization of LYTENAVA™ ( [...]
Daré Bioscience CEO, Sabrina Martucci Johnson, Participates in the Virtual Investor “Why Now” On-Demand Series
27/08/2026
Video webcast now available here SAN DIEGO, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women's health between [...]
AIM ImmunoTech Participates in the Virtual Investor ‘Why Now’ On-Demand Conference
27/08/2026
Video webcast now available here OCALA, Fla., Aug. 27, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that it participated in the Virtual Investor "Why Now" on [...]
POSSIBLE® by Standard Process® Launches Peanut Butter Banana Cacao Snack Bar
27/08/2026
A Whole Food Snack Bar Designed to Support Real Life PALMYRA, Wis., Aug. 27, 2026 (GLOBE NEWSWIRE) -- POSSIBLE ® by Standard Process ® today announced the launch of its new POSSIBLE ® Peanut Butter Banana Cacao Snack [...]

Pages